Details From Head-to-Head Phase 3 Test Give Fuller Picture of Zepbound’s Edge Over Wegovy

Eli Lilly reported that in addition to achieving greater reductions in weight, Zepbound-treated patients achieved greater reductions in waist circumference compared to those treated with Novo Nordisk’s Wegovy. Full details from the head-to-head Phase 3 test were presented at the European Congress on Obesity meeting. The post Details From Head-to-Head Phase 3 Test Give Fuller…

Read More

Reducing Care Gaps Through Payer Insights

[Sponsored] Megan Zakrewsky, Vice President of Product, talked about how Veradigm is working with primary care providers to provide timely patient information without adding to their administrative burden. The post Reducing Care Gaps Through Payer Insights appeared first on MedCity News.

Read More

Readers Scrutinize Federal Cuts and Medical Debt

Letters to the Editor is a periodic feature. We welcome all comments and will publish a selection. We edit for length and clarity and require full names. Trump Team’s Rhetoric Doesn’t Match Actions The recent KFF Health News article “Beyond Ivy League, RFK Jr.’s NIH Slashed Science Funding Across States That Backed Trump” (April 17) struck a nerve….

Read More